Wels, W <br/><br/>
EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins.  [electronic resource] 

 -  International journal of cancer  Jan 1995 
 - 137-44 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.2910600120  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP Ribose Transferases<br/>Amino Acid Sequence<br/>Animals<br/>Antibodies, Monoclonal<br/>Antibody Specificity<br/>Bacterial Toxins<br/>Base Sequence<br/>Breast Neoplasms--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Division--drug effects<br/>Cell Survival--drug effects<br/>ErbB Receptors--genetics<br/>Exotoxins--genetics<br/>Female<br/>Humans<br/>Immunotoxins--toxicity<br/>Mice<br/>Mice, Nude<br/>Molecular Sequence Data<br/>Neoplasm Proteins--genetics<br/>Receptor, ErbB-2--genetics<br/>Recombinant Fusion Proteins--genetics<br/>Sensitivity and Specificity<br/>Virulence Factors<br/>Vulvar Neoplasms--drug therapy<br/>Pseudomonas aeruginosa Exotoxin A